Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
(NASDAQ: PSNL) Delayed: 16.23 +0.12 (0.74%)
Previous Close $16.11    52 Week High $ 
Open $16.42    52 Week Low $ 
Day High $16.45    P/E N/A 
Day Low $16.13    EPS $ 
Volume 5,649,428       

StemCells, Inc. (NASDAQ: TEM) Delayed: 80.36 +10.39 (14.85%)
Previous Close $69.97    52 Week High $0.45 
Open $72.70    52 Week Low $0.37 
Day High $81.28    P/E N/A 
Day Low $72.61    EPS $-0.31 
Volume 17,120,033